• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在兔肝脏中使用不同的碘油乳剂和载药微球进行经动脉化疗栓塞后,比较阿霉素在组织中的药代动力学和药物释放情况。

Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers.

作者信息

Zhang Shuisheng, Huang Can, Li Zhengzheng, Yang Yongjie, Bao Tingting, Chen Haibo, Zou Yinghua, Song Li

机构信息

a Department of Interventional Radiology and Vascular Surgery , Peking University First Hospital , Beijing , China.

b Department of Radiology, Beijing Chaoyang Hospital , Capital Medical University , Beijing , China.

出版信息

Drug Deliv. 2017 Nov;24(1):1011-1017. doi: 10.1080/10717544.2017.1344336.

DOI:10.1080/10717544.2017.1344336
PMID:28660787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8241087/
Abstract

CalliSpheres Beads (CB) is the first drug-eluting bead (DEB) product in China. Our aim was to compare the effect on the pharmacokinetics of doxorubicin (DOX) and its local concentration between lipiodol emulsions and CB in the process of TACE in rabbit livers. Twenty-five rabbits were distributed into two groups; Group 1 received lipiodol emulsions with DOX, and Group 2 received CB loaded with DOX (CBDOX). DOX was measured in the peripheral blood at different times after treatment. Livers were sampled at 1 week and 1 month for Group 2 after embolization. DOX concentration and distribution were measured in the liver. The administration of DOX by TACE with CBDOX resulted in peripheral blood DOX concentrations of 39.85 ± 13.86 ng/mL at 5 min, with a gradual decrease to 6.89 ± 1.62 ng/mL at 24 h, after treatment. Plasma concentration of DOX after chemoembolization with lipiodol was 225.91 ± 64.88 ng/mL at 5 min and decreased with time by 24 h to 5.06 ± 0.48 ng/mL. In CBDOX group, the drug impregnated an area as far as 200 μm from the bead edge. The tissue concentration of doxorubicin (tissC) ranged from 40.27 μg/mL to 245.70 μg/mL at 1 week and from 5.64 μg/mL to 28.09 μg/mL at 1 month. Plasma concentrations of DOX resulting from CBDOX embolization were significantly lower than that for cTACE. CB could deliver relatively high concentrations of DOX to an area as far as 200 μm from the bead edge for at least 1 month.

摘要

载药微球(CB)是中国首个药物洗脱微球(DEB)产品。我们的目的是比较碘油乳剂和CB在兔肝TACE过程中对阿霉素(DOX)药代动力学及其局部浓度的影响。25只兔子分为两组;第1组接受含DOX的碘油乳剂,第2组接受载有DOX的CB(CBDOX)。治疗后不同时间点检测外周血中的DOX。第2组在栓塞后1周和1个月取肝脏样本。检测肝脏中DOX的浓度和分布。用CBDOX进行TACE给药后,治疗后5分钟外周血DOX浓度为39.85±13.86 ng/mL,24小时逐渐降至6.89±1.62 ng/mL。碘油化疗栓塞后5分钟DOX血浆浓度为225.91±64.88 ng/mL,24小时随时间下降至5.06±0.48 ng/mL。在CBDOX组,药物浸渍到距微球边缘200μm的区域。阿霉素组织浓度(tissC)在1周时为40.27μg/mL至245.70μg/mL,1个月时为5.64μg/mL至28.09μg/mL。CBDOX栓塞导致的DOX血浆浓度显著低于cTACE。CB可将相对高浓度的DOX输送到距微球边缘至少200μm的区域至少1个月。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9912/8241087/390047a1a761/IDRD_A_1344336_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9912/8241087/4f81e0aca3c5/IDRD_A_1344336_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9912/8241087/59179a4e8832/IDRD_A_1344336_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9912/8241087/390047a1a761/IDRD_A_1344336_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9912/8241087/4f81e0aca3c5/IDRD_A_1344336_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9912/8241087/59179a4e8832/IDRD_A_1344336_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9912/8241087/390047a1a761/IDRD_A_1344336_F0003_C.jpg

相似文献

1
Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers.在兔肝脏中使用不同的碘油乳剂和载药微球进行经动脉化疗栓塞后,比较阿霉素在组织中的药代动力学和药物释放情况。
Drug Deliv. 2017 Nov;24(1):1011-1017. doi: 10.1080/10717544.2017.1344336.
2
Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.使用不同的碘油乳剂和药物洗脱微球经动脉化疗栓塞术后的药物释放及药代动力学比较。
PLoS One. 2014 Dec 31;9(12):e115898. doi: 10.1371/journal.pone.0115898. eCollection 2014.
3
CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.载药微球与碘化油动脉化疗栓塞治疗肝细胞癌的短期疗效及安全性比较:一项短期疗效和安全性研究。
World J Surg Oncol. 2018 Mar 27;16(1):69. doi: 10.1186/s12957-018-1368-8.
4
Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads.新型经动脉化疗栓塞制剂的评价:将 Lipiodol 乳剂与载药微球的元素相结合。
Theranostics. 2019 Jul 28;9(19):5626-5641. doi: 10.7150/thno.34778. eCollection 2019.
5
Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.前瞻性研究碘油分布作为常规经动脉化疗栓塞治疗肝恶性肿瘤时阿霉素药代动力学的成像标志物。
Eur Radiol. 2021 May;31(5):3002-3014. doi: 10.1007/s00330-020-07380-w. Epub 2020 Oct 15.
6
Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.经放射性标记载药微球栓塞兔肿瘤模型后 CT 图像上药物剂量分布的描绘。
Radiology. 2018 Nov;289(2):396-404. doi: 10.1148/radiol.2018172571. Epub 2018 Aug 14.
7
Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.在 VX2 兔肿瘤模型中,索拉非尼和多柔比星常规经肝动脉化疗栓塞的药代动力学和早期肿瘤反应。
J Vasc Interv Radiol. 2022 Oct;33(10):1213-1221.e5. doi: 10.1016/j.jvir.2022.07.011. Epub 2022 Jul 16.
8
Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.用于肝细胞癌经动脉化疗栓塞的胆酸钠胆汁酸稳定的多柔比星-碘油-铁氧体纳米颗粒乳剂
J Vasc Interv Radiol. 2020 Oct;31(10):1697-1705.e3. doi: 10.1016/j.jvir.2020.01.026. Epub 2020 Aug 6.
9
Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy.聚合物泡囊稳定的多柔比星-碘油乳剂用于高效化疗栓塞治疗。
J Control Release. 2022 Oct;350:122-131. doi: 10.1016/j.jconrel.2022.08.015. Epub 2022 Aug 17.
10
Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.载药介孔有机硅包覆四氧化三铁磁性纳米颗粒联合碘化油经导管动脉化疗栓塞抑制肝癌进展
J Colloid Interface Sci. 2021 Jun;591:211-220. doi: 10.1016/j.jcis.2021.02.022. Epub 2021 Feb 10.

引用本文的文献

1
Comparison of liver injury and inflammatory response following conventional and drug-eluting bead transcatheter chemoembolization in hepatocellular carcinoma.肝细胞癌中传统经导管肝动脉化疗栓塞术与载药微球经导管肝动脉化疗栓塞术后肝损伤及炎症反应的比较
Discov Oncol. 2025 Apr 10;16(1):504. doi: 10.1007/s12672-025-02286-9.
2
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study.基于FOLFOX方案的肝动脉灌注化疗序贯载药微球经动脉化疗栓塞治疗不可切除的大肝细胞癌:一项单中心回顾性队列研究
J Hepatocell Carcinoma. 2024 Oct 28;11:2087-2099. doi: 10.2147/JHC.S493577. eCollection 2024.
3

本文引用的文献

1
[Development of CalliSpheres® embolic microspheres].[CalliSpheres®栓塞微球的研发]
Zhonghua Gan Zang Bing Za Zhi. 2016 Jul 20;24(7):549-551. doi: 10.3760/cma.j.issn.1007-3418.2016.07.016.
2
Efficacy and safety of cTACE versus DEB-TACE in patients with hepatocellular carcinoma: a meta-analysis.经动脉化疗栓塞术(cTACE)与载药微球经动脉化疗栓塞术(DEB-TACE)治疗肝细胞癌患者的疗效和安全性:一项荟萃分析。
J Dig Dis. 2016 Aug;17(8):510-517. doi: 10.1111/1751-2980.12380.
3
Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis.
Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study.
DEB-TACE 与 C-TACE 治疗不可切除肝细胞癌的短期疗效和安全性的比较研究:一项回顾性研究。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241250315. doi: 10.1177/15330338241250315.
4
Is ALPPS still appropriate for large or locally advanced hepatocellular carcinoma in an era of targeted agents and immunotherapy?在靶向药物和免疫治疗时代,ALPPS 对于大肝癌或局部进展期肝癌仍然适用吗?
Updates Surg. 2024 Jun;76(3):899-910. doi: 10.1007/s13304-024-01789-4. Epub 2024 Mar 25.
5
Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis.CalliSpheres® 微球与常规经动脉化疗栓塞治疗难治性结直肠癌肝转移的疗效比较。
BMC Cancer. 2023 Oct 12;23(1):970. doi: 10.1186/s12885-023-11350-y.
6
In vitro comparative study of multimodal imaging nano-assembled microspheres with two clinical drug-eluting beads loaded with doxorubicin.载多柔比星的两种临床载药微球的纳米组装型多功能成像微球的体外对比研究。
Drug Deliv. 2023 Dec;30(1):2197177. doi: 10.1080/10717544.2023.2197177.
7
Comparison of CalliSpheres microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial.载药微球与常规 TACE 治疗肝细胞癌的随机对照研究
Radiol Oncol. 2023 Feb 17;57(1):70-79. doi: 10.2478/raon-2023-0001. eCollection 2023 Mar 1.
8
A 3D Tumor-Mimicking In Vitro Drug Release Model of Locoregional Chemoembolization Using Deep Learning-Based Quantitative Analyses.基于深度学习的定量分析的局部化疗栓塞的三维肿瘤模拟体外药物释放模型。
Adv Sci (Weinh). 2023 Apr;10(11):e2206195. doi: 10.1002/advs.202206195. Epub 2023 Feb 15.
9
Microspheres as a Carrier System for Therapeutic Embolization Procedures: Achievements and Advances.作为治疗性栓塞程序载体系统的微球:成就与进展
J Clin Med. 2023 Jan 24;12(3):918. doi: 10.3390/jcm12030918.
10
DEB-TACE with irinotecan C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical study.伊立替康载药微球经动脉化疗栓塞术对比传统经动脉化疗栓塞术治疗不可切除性肝内胆管癌的前瞻性临床研究
Front Bioeng Biotechnol. 2023 Jan 12;10:1112500. doi: 10.3389/fbioe.2022.1112500. eCollection 2022.
经动脉化疗栓塞联合放疗治疗伴有门静脉癌栓的肝细胞癌的疗效:一项倾向评分分析。
Hepatol Res. 2016 Oct;46(11):1088-1098. doi: 10.1111/hepr.12657. Epub 2016 Mar 24.
4
Evaluation of 70-150-μm doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model.在兔肝VX2肿瘤模型中评估70 - 150μm阿霉素洗脱微球用于经动脉化疗栓塞的效果
Eur Radiol. 2016 Oct;26(10):3474-82. doi: 10.1007/s00330-015-4197-y. Epub 2016 Jan 15.
5
Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.乙型肝炎病毒流行地区不可切除的非转移性肝细胞癌经动脉化疗栓塞再治疗评分评估的验证与重新评估
Eur Radiol. 2016 Oct;26(10):3510-8. doi: 10.1007/s00330-015-4185-2. Epub 2016 Jan 8.
6
Doxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor.阿霉素纳米泡用于兔VX2肝肿瘤的超声检查与靶向化疗联合治疗
Tumour Biol. 2016 Jul;37(7):8673-80. doi: 10.1007/s13277-015-4525-5. Epub 2016 Jan 6.
7
Nursing Implications of Chemotherapy Agents and Their Associated Side Effects in Patients With Pancreatic Cancer.化疗药物及其相关副作用对胰腺癌患者的护理影响
Clin J Oncol Nurs. 2015 Dec;19(6):751-7. doi: 10.1188/15.CJON.751-757.
8
Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.经动脉化疗栓塞术(TACE)联合经皮乙醇注射术(PEI)治疗不可切除肝细胞癌:一项随机对照试验的荟萃分析
Int J Clin Exp Med. 2015 Jul 15;8(7):10388-400. eCollection 2015.
9
Long term side effects of adjuvant chemotherapy in patients with early breast cancer.早期乳腺癌患者辅助化疗的长期副作用。
Breast. 2015 Nov;24 Suppl 2(0 2):S149-53. doi: 10.1016/j.breast.2015.07.035. Epub 2015 Aug 20.
10
Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.合成修饰的病毒衣壳作为基于抗体的细胞靶向的通用载体
Bioconjug Chem. 2015 Aug 19;26(8):1590-6. doi: 10.1021/acs.bioconjchem.5b00226. Epub 2015 Jul 6.